>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
冠状动脉微循环障碍的检测与治疗
作者:卢周舟  童嘉毅 
单位:东南大学 医学院, 江苏 南京 210009
关键词:冠状动脉微循环障碍 检测方法 治疗 预防 文献综述 
分类号:R541.4
出版年·卷·期(页码):2015·34·第四期(657-660)
摘要:

冠状动脉微循环比起可以在造影下观察的心外膜冠状动脉而言,在心肌中的分布要广泛得多,但他们不能在造影下可见。过去因为技术的原因,人们没有认识到冠脉微循环的临床意义,然而在近些年里,越来越多证据表明,冠状动脉微循环的功能和结构的异常可能导致心肌缺血甚至心脏功能障碍。作者综述了近年来冠状动脉微循环障碍的检测及治疗的进展。

参考文献:

[1] WONG D T,LEUNG M C,RICHARDSON J D,et al.Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function:a comparison of angiographic and cardiac magnetic resonance derived measurements[J].Cardiovasc Imaging,2012,28:1971-1981.
[2] YONG A S,HO M,SHAH M G,et al.Coronary microcirculatory resistance is independent of epicardial stenosis[J].Circ Cardiovasc Interv,2012,5:103-108,S1-2.
[3] MASERI A.Ischemic heart disease[M].New York:Churchill Livingstone,1995:243.
[4] ONG P,ATHANASIADIS A,BORGULYA G,et al.Highprevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries.The ACOVA Study[J].Coll Cardiol,2012,59:655-662.
[5] 闫磊,童嘉毅.冠状动脉微循环障碍概述及研究进展[J].现代医学,2013,13(8):589-591.
[6] OSTO E,CASTELLANI C,FADINI G P,et al.Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy[J].Heart Lung Transplant,2011,30:70-76.
[7] ZIADI M,BEANLANDS R.The clinical utility of assessing myocardial blood flow using position emission tomogmphy[J].Nucl Cardiol,2010,17:571-581.
[8] JESPERSEN L,HVELPLUND A,ABILDSTROM S Z,et al.Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events[J].Eur Heart,2012,33:734-744.
[9] TAHK S J,CHOI B J,CHOI S Y,et al.Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction:a prospective,randomized,multicenter trial[J].Cardiol,2008,123:162-168.
[10] GAETANO A,LANZA,PAOLO G,et al.Methods to investigate coronary microvascular function in clinical practice[J].Cardiovasc Med,2013,14:1-18.
[11] GOEL P K,GUPTA S K,AGARWAL A,et al.Slow coronary flow:a distinct angiographic subgroup in syndrome X[J].Angiology,2001,52(8):507-514.
[12] RAQUEL P A,PAUL F A T,KOEN M M,et al.Invasive measurement of coronary microvascular resistance in patients with acute myocardial infarction treated by primary PCI[J].Heart,2013,100:13-20.
[13] AARNOUDSE W,van den BERG P,van de VOSSE F,et al.Myocardial resistance assessed by guidewire-based pressure-temperature measurement:in vitro validation[J].Catheter Cardiovasc Interv,2004,62:56-63.
[14] NG M K,YEUNG A C,FEARON W F.Invasive assessment of the coronary microcirculation:superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve[J].Circulation,2006,113:2054-2061.
[15] JOERG H,JUAN C K.Coronary microvascular dysfunction in the clinical setting:from mystery to reality[J].Eur Heart J,2012,33:2771-2781.
[16] KIVINIEMI T.Assessment of coronary blood flow and the reactivity of the microcirculation noninvasively with transthoracic echocardiography[J].Clin Physiol Funct Imaging,2008,28:145-155.
[17] MEIMOUN P,TRIBOUILLOY C.Noninvasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography:a magic tool for the real world[J].Echocardiogr,2008,9:449-457.
[18] KOLLER A,BALASKO M,BAGI Z.Endothelial regulation of coronary microcirculation in health and cardiometabolic diseases[J].Intern Emerg Med,2013,8(1):S51-S54.
[19] SENIOR R,BECHER H,MONAGHAN M,et al.Contrast echocardiography:evidence-based recommendations by European Association of Echocardiography[J].Echocardiogr,2009,10:194-212.
[20] BERWICK Z C,DICK G M,TUNE J D.Heart of the matter:coronary dysfunction in metabolic syndrome[J].Mol Cell Cardiol,2012,52(4):848-856.
[21] WALLER C,HILLER K H,ALBRECHT M,et al.Microvascular adaptation to coronary stenosis in the rat heart in vivo:a serial magnetic resonance imaging study[J].Microvasc Res,2003,66(3):173-182.
[22] MONTALESCOT G,Van de WERF F,GULBA D C,et al.Stenting and glycoprotein Ⅱb/Ⅲa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention:findings from the global registry of acute coronary events(GRACE)[J].Catheter Cardiovasc Interv,2003,60(3):360-367.
[23] KLONER R A,FORMAN M B,GIBBONS R J,et al.Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction:the AMISTAD-2 trial[J].Cardiol,2006,97(12):1778-1784.
[24] SILVA-ORREGO P,COLOMBO P,BIGI R,et al.Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction:the DEAR-MI(dethrombosis to enhance acute reperfusion in myocardial infarction)study[J].Coll Cardiol,2006,48(8):1552-1559.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414324 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364